GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (OTCPK:CBSTF) » Definitions » EBIT

CBSTF (Cannabist Company Holdings) EBIT : $-51.5 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings EBIT?

Cannabist Company Holdings's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was $30.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was $-51.5 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cannabist Company Holdings's annualized ROC % for the quarter that ended in Sep. 2024 was 0.29%. Cannabist Company Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 27.28%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cannabist Company Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -10.84%.


Cannabist Company Holdings EBIT Historical Data

The historical data trend for Cannabist Company Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings EBIT Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial -103.90 -129.51 -116.70 -378.80 -114.03

Cannabist Company Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.14 -71.12 -16.23 5.79 30.03

Competitive Comparison of Cannabist Company Holdings's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabist Company Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's EV-to-EBIT falls into.



Cannabist Company Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-51.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabist Company Holdings  (OTCPK:CBSTF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cannabist Company Holdings's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=-22.02 * ( 1 - 108.78% )/( (684.984 + 653.377)/ 2 )
=1.933356/669.1805
=0.29 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=777.115 - 134.718 - ( 22.332 - max(0, 209.845 - 167.258+22.332))
=684.984

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=770.702 - 137.882 - ( 31.497 - max(0, 255.532 - 234.975+31.497))
=653.377

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Cannabist Company Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=120.116/( ( (493.728 + max(1.895, 0)) + (384.845 + max(-6.4630000000001, 0)) )/ 2 )
=120.116/( ( 495.623 + 384.845 )/ 2 )
=120.116/440.234
=27.28 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(13.505 + 116.131 + 14.837) - (134.718 + 0 + 7.86)
=1.895

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(15.371 + 89.717 + 79.865) - (137.882 + 0 + 53.534)
=-6.4630000000001

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cannabist Company Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=-51.525/475.537
=-10.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabist Company Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabist Company Holdings Business Description

Traded in Other Exchanges
Address
680 Fifth Avenue, 24th Floor, New York, NY, USA, 10019
Cannabist Company Holdings Inc is a cultivator, manufacturer, and provider of medical cannabis products and services. Some of its products are Vaporization Oil, Sublingual Tinctures, Lotions, Hard Pressed Tablets, and Suppositories, among others. The company markets its products under ClaraCeed, Seed & Starin, and Triple 777 brands among others.
Executives
David Sirolly officer: Chief Legal Officer/GC C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Julie A Hill director WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Jeff Clarke director COMPUTER ASSOCIATES INTERNATIONAL INC, ONE COMPUTER ASSOCIATES PLAZA, ISLANDA NY 11746
Derek Watson officer: Chief Financial Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
David James Hart officer: Chief Operating Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Alison Worthington director C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Bryan Olson officer: Chief People/Admin Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Nicholas Vita director, officer: Chief Executive Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Rosemary Mazanet officer: Chief Scientific Officer 175 TOYOTA PLAZA, 7TH FLOOR, MEMPHIS TN 38103
Guy Hussussian officer: Chief Data Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Jesse Channon officer: Chief Growth Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Michael Abbott director, officer: Chairman C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Philip Goldberg director C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Frank Savage director
Kennedy James A C director T ROWE PRICE GROUP INC, 100 E PRATT ST, BALTIMORE MD 21202

Cannabist Company Holdings Headlines

From GuruFocus

Columbia Care Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Q2 2023 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2022 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2021 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024

Columbia Care Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Q4 2020 Columbia Care Inc Earnings Call Transcript

By GuruFocus Research 02-13-2024